Deals this week: OptiNose, Dermira, Aadi Bioscience

OptiNose has completed a series D venture financing round to raise funds required for the commercialisation and launch of its lead product candidate, OPN-375, in the US.

Source: Drug Development Technology - May 11, 2017 Category: Pharmaceuticals Source Type: news